26 May, 2017
The fund purchased 300,771 shares of the company's stock, valued at approximately $8,217,000.
Several other brokerages have also recently weighed in on AZN. Finally, Ameriprise Financial Inc. raised its position in shares of AstraZeneca plc by 23.8% in the first quarter.
Earnings per share (EPS) breaks down the profitability of the company on a single share basis, and for AstraZeneca PLC the EPS stands at 0.61 for the previous quarter, while the analysts predicted the EPS of the stock to be 0.59, suggesting the stock exceeded the analysts' expectations. Crawford Investment Counsel Inc. now owns 470,235 shares of the company's stock valued at $15,452,000 after buying an additional 84,390 shares during the period. Northwest Quadrant Wealth Management LLC purchased a new stake in AstraZeneca plc during the fourth quarter valued at $129,000. Asset Planning Services Ltd. now owns 5,100 shares of the company's stock worth $139,000 after buying an additional 4,400 shares during the last quarter. Mirae Asset Global Investments Co. Wells Fargo & Company MN raised its position in shares of AstraZeneca plc by 41.6% in the first quarter. Capital International Investors now owns 20,600,179 shares of the company's stock worth $676,922,000 after buying an additional 126,700 shares in the last quarter. Quadrant Capital Group LLC increased its stake in AstraZeneca plc by 157.1% in the first quarter. Tributary Capital Management Llc acquired 12,835 shares as Umb Financial Corp (UMBF)'s stock declined 12.47%. Hedge funds and other institutional investors own 12.90% of the company's stock.
AstraZeneca plc (LON:AZN) traded up 0.46% during trading on Monday, hitting GBX 5209.00. 2,606,058 shares of the stock traded hands.
Stock is now moving with a positive distance from the 200 day simple moving average of approximately 13.82%, and has a solid year to date (YTD) performance of 25.44% which means the stock is constantly adding to its value from the previous fiscal year end price. The firm has a market capitalization of $86.77 billion, a P/E ratio of 25.67 and a beta of 0.77.
AZN has a 1-year high price of $ 35.04 and 1-year low price of $25.55.
AstraZeneca plc (NYSE:AZN) last announced its quarterly earnings results on Thursday, April 27th. The company reported $0.99 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.38 by $0.61. The firm had revenue of $5.41 billion for the quarter, compared to the consensus estimate of $5.40 billion.
AstraZeneca plc (LON:AZN) has been assigned a GBX 3,900 ($50.74) price target by research analysts at Goldman Sachs Group Inc in a research note issued on Friday. Shore Capital restated a "sell" rating on shares of AstraZeneca plc in a research report on Tuesday, February 28th. FBR Capital initiated it with "Mkt Perform" rating and $80 target in Tuesday, January 10 report. If you are accessing this article on another website, it was illegally copied and reposted in violation of USA and worldwide trademark & copyright legislation. The correct version of this piece of content can be viewed at https://transcriptdaily.com/2017/05/25/300771-shares-in-astrazeneca-plc-azn-acquired-by-norges-bank-updated.html.
AZN has been the subject of a number of analyst reports. TheStreet upgraded shares of AstraZeneca plc from a "c+" rating to a "b-" rating in a report on Tuesday, February 28th. On Friday, July 31 the stock rating was upgraded by Swedbank to "Buy". HSBC Holdings plc downgraded shares of AstraZeneca plc from a "hold" rating to a "reduce" rating in a research report on Friday, April 7th. Five analysts have rated the stock with a sell rating, seven have issued a hold rating and nine have issued a buy rating to the company's stock. The company presently has an average rating of "Hold" and a consensus price target of $35.84.
AstraZeneca plc (ADR) had 26 analyst reports since July 31, 2015 according to SRatingsIntel.
Marina Biotech, Inc.is a biotechnology firm focused on the discovery, development and commercialization of nucleic acid therapies to treat orphan diseases.